Apretude
(cabotegravir long-acting for PrEP)
Apretude is an HIV-1 integrase strand transfer inhibitor (INSTI).
Cabotegravir LA for Prevention
Cabotegravir is a long-acting, injectable human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor that has been studied for PrEP.
Pre-Exposure Prophylaxis (PrEP) is the use of medicine taken before HIV exposure to help prevent HIV infection. Cabotegravir LA is an HIV-1 integrase strand transfer inhibitor indicated in at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test prior to initiating cabotegravir for HIV-1 PrEP.
ViiVCONNECT
Comprehensive information on access and coverage to help patients get their prescribed ViiV Healthcare medications